Article Versions Notes

Baas J, Bieringer S, Frias C, Frias J, Soehnchen C, Urmann C, Ritter S, Riepl H, Prokop A. Dihydroxyquingdainone Induces Apoptosis in Leukaemia and Lymphoma Cells via the Mitochondrial Pathway in a Bcl-2- and Caspase-3-Dependent Manner and Overcomes Resistance to Cytostatic Drugs In Vitro. Molecules. 2022; 27(15):5038. https://doi.org/10.3390/molecules27155038

Baas, Jennifer, Sebastian Bieringer, Corazon Frias, Jerico Frias, Carolina Soehnchen, Corinna Urmann, Steffi Ritter, Herbert Riepl, and Aram Prokop. 2022. "Dihydroxyquingdainone Induces Apoptosis in Leukaemia and Lymphoma Cells via the Mitochondrial Pathway in a Bcl-2- and Caspase-3-Dependent Manner and Overcomes Resistance to Cytostatic Drugs In Vitro" Molecules 27, no. 15: 5038. https://doi.org/10.3390/molecules27155038

Baas, J., Bieringer, S., Frias, C., Frias, J., Soehnchen, C., Urmann, C., Ritter, S., Riepl, H., & Prokop, A. (2022). Dihydroxyquingdainone Induces Apoptosis in Leukaemia and Lymphoma Cells via the Mitochondrial Pathway in a Bcl-2- and Caspase-3-Dependent Manner and Overcomes Resistance to Cytostatic Drugs In Vitro. Molecules, 27(15), 5038. https://doi.org/10.3390/molecules27155038